Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06369285
Status:
RECRUITING
Last Update Posted:
2024-04-16
First Post:
2024-04-12
Brief Title:
A Study of Alisertib in Combination with Endocrine Therapy in Patients with HR-positive HER2-negative Recurrent or Metastatic Breast Cancer
Sponsor:
Organization:
Puma Biotechnology Inc